Uterine cancer survival statistics

Survival

Survive uterine cancer for 10 or more years, 2010-11, England and Wales

Age

Age that uterine cancer survival is highest, 2009-2013, England

 

Improvement

Uterine cancer survival in the UK has increased in the last 40 years

 

90% of women survive uterine cancer for at least one year, and this is predicted to fall to 79% surviving for five years or more, as shown by age-standardised Open a glossary item  net survival  for patients diagnosed with uterine cancer during 2010-2011 in England and Wales. [1]

Uterine Cancer (C54-C55), Age-Standardised One-, Five- and Ten-Year Net Survival, Women (Aged 15-99), England and Wales, 2010-2011

1-Year Survival (%) 5-Year Survival (%) 10-Year Survival (%)
Women Net Survival 90.3 79.0 77.5
95% LCL 90.3 79.0 77.4
95% UCL 90.3 79.0 77.6

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item

Five- and ten-year survival is predicted using an excess hazard statistical model

Uterine cancer survival falls only slightly beyond five years after diagnosis, which means most patients can be considered cured after five years. 78% of women are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with uterine cancer during 2010-2011 in England and Wales.[1] Out of 20 common cancers in England and Wales, ten-year survival for uterine cancer ranks 6th highest overall (and 4th highest for females only).

Uterine Cancer (C54-C55), Net Survival up to Ten Years after Diagnosis, Women (Aged 15-99), England and Wales, 2010-2011

Survival for uterine cancer is reported in Scotland and Northern Ireland,[2,3] though it is difficult to make survival comparisons between countries due to different methodologies and criteria for including patients in analyses.

References

  1. Data were provided by London School of Hygiene and Tropical Medicine on request, 2014. 
  2. ISD Scotland. Trends in Cancer Survival 1983-2007
  3. Northern Ireland Cancer Registry. Incidence & Survival 1993-2012.
Last reviewed:

Five-year survival for uterine cancer generally decreases with increasing age. Five-year net survival ranges from 87% in 15-39 year-olds to 57% in 80-99 year-olds for patients diagnosed with uterine cancer in England during 2009-2013.[1]

Uterine Cancer (C54-C55), Five-Year Net Survival by Age, Women, England, 2009-2013

Last reviewed:

As with most cancers, survival for uterine cancer is improving. One-year age-standardised Open a glossary item net survival has increased from 75% during 1971-1972 to 90% during 2010-2011 in England and Wales – an absolute survival difference Open a glossary item of 15 percentage points.[1]

Uterine Cancer (C54-C55), Age-Standardised One-Year Net Survival, Women (Aged 15-99), England and Wales, 1971-2011

Five- and ten-year survival has increased by an even greater amount than one-year survival since the early 1970s. Five-year age-standardised net survival for uterine cancer has increased from 59% during 1971-1972 to a predicted survival of 79% during 2010-2011 in England and Wales – an absolute survival difference of 20 percentage points.[1]

Uterine Cancer (C54-C55), Age-Standardised Five-Year Net Survival, Women (Aged 15-99), England and Wales, 1971-2011

Five-year survival for 2010-2011 is predicted using an excess hazard statistical model

Ten-year age-standardised net survival for uterine cancer has increased from 55% during 1971-1972 to a predicted survival of 78% during 2010-2011 in England and Wales - an absolute survival difference of 22 percentage points.[1] Overall, more than three-quarters of women diagnosed with uterine cancer today are predicted to survive their disease for at least ten years.

Uterine Cancer (C54-C55), Age-Standardised Ten-Year Net Survival, Women (Aged 15-99), England and Wales, 1971-2011

Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model

Last reviewed:

Survival for uterine cancer is strongly related to stage of the disease at diagnosis.

One-year net survival for uterine cancer is highest for patients diagnosed at stage I, and lowest for those diagnosed at stage IV, 2014 data for England show.[1] 99% of patients diagnosed at stage I survived their disease for at least one year, versus 45% patients diagnosed at stage IV.[1]

One-year net survival for unknown stage uterine cancer is 53%. Lack of staging information may in some cases reflect advanced stage at diagnosis: for example very unwell patients may not undergo staging tests if the invasiveness of the testing outweighs the potential benefit of obtaining stage information.[1]

Uterine Cancer (C54-C55), One-Year Age Standardised Net Survival by Stage, Adults (Ages 15-99 Years), England 2014

Five-year survival for uterine cancer shows a much more rapid decrease in survival between Stages I and IV. Five-year relative survival ranges from 95% at Stage I to 14% at Stage IV for patients diagnosed during 2002-2006 in the former Anglia Cancer Network.[1]

Cancer of the Body of the Uterus (C54), Five-Year Relative Survival by Stage, Women (Aged 15-99 Years), Former Anglia Cancer Network, 2002-2006

References

  1. Office for National Statistics, Cancer survival by stage at diagnosis for England, 2016.
  2. Data were provided by The National Cancer Registration Service Eastern Office on request. Similar data can be found here: http://www.ncras.nhs.uk/ncrs-east/

About this data

Data is for: England, 2014 (one-year), Former Anglia Cancer Network, 2002-2006 (five-year), ICD-10 C54-C55

Survival statistics give an overall picture of survival and the survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Last reviewed:

For women diagnosed in 1996-1999 there is a significant gap in five-year survival between the most deprived and least deprived women of 4.5%.[1] Regional differences in survival rates reflect this deprivation gradient. Wales had the lowest relative one and five-year survival rates for women diagnosed in 1986-90, while the South and West regions in England had the highest rates.[2]

References

  1. Coleman MP, Rachet B, Woods LM, et al. Trends in socioeconomic inequalities in cancer survival in England and Wales up to 2001. BJC 2004;90(7):1367-73. 
  2. Coleman MP, Babb P, Damiecki P, et al. Cancer Survival Trends in England and Wales, 1971-1995: Deprivation and NHS Region. Series SMPS No 61. London: ONS; 1999.
Last reviewed:

Five-year relative survival for uterine cancer in women in England (76%) is similar to the average for Europe (76%). Wales (74%), Scotland (77%) and Northern Ireland (74%) are also similar to the European average.[1] Across the European countries for which data is available, five-year relative survival in women ranges from 70% (Bulgaria) to 85% (Sweden).[1

Uterine Cancer (C54), Age-Standardised Five-Year Relative Survival, Females (Aged 15+), European Countries, 2000-2007

Data consists of both observed and predicted 5-year relative survival. Where sufficient follow-up was not available for recently diagnosed patients the period approach was used to predict 5-year cohort survival.

Possible explanations for persistent international differences in survival include differences in cancer biology, use of diagnostic tests and screening, stage at diagnosis, access to high-quality care, and data collection practices.[1]

References

  1. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol 2014;15:23-34

About this data

Data is for: 29 European countries, patients diagnosed in 2000-2007 and followed up to 2008, uterine cancer (C54).

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Rate this page:

Currently rated: 2.5 out of 5 based on 12 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page